CGON - CG Oncology, Inc. Common stock -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
CG Oncology, Inc. Common stock
IPO Date: January 25, 2024
Sector: Healthcare
Industry: Biotech
Market Cap: $6.61B
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.16 | 2.89%
Avg Daily Range (30 D): $1.36 | 1.80%
Avg Daily Range (90 D): $1.72 | 2.49%
Institutional Daily Volume
Avg Daily Volume: .72M
Avg Daily Volume (30 D): .52M
Avg Daily Volume (90 D): .67M
Trade Size
Avg Trade Size (Sh.): 64
Avg Trade Size (Sh.) (30 D): 49
Avg Trade Size (Sh.) (90 D): 50
Institutional Trades
Total Institutional Trades: 2,023
Avg Institutional Trade: $3.64M
Avg Institutional Trade (30 D): $6.01M
Avg Institutional Trade (90 D): $6M
Avg Institutional Trade Volume: .08M
Avg Institutional Trades (Per Day): 3
Market Closing Trades
Avg Closing Trade: $6.31M
Avg Closing Trade (30 D): $13.44M
Avg Closing Trade (90 D): $15.14M
Avg Closing Volume: 140.94K
 
News
Sep 8, 2026 @ 10:20 AM
Should You Invest in the ALPS Medical Breakthrough...
Source: Na
Sep 2, 2026 @ 12:00 PM
CG Oncology to Present at Upcoming Investor Confer...
Source: Na
Jul 29, 2026 @ 11:39 PM
Kuehn Law Encourages Investors of CG Oncology, Inc...
Source: Kuehn Law, Pllc
Jul 27, 2026 @ 10:45 PM
CG Oncology Announces Publication of Pivotal Phase...
Source: Cg Oncology, Inc.
May 15, 2026 @ 12:00 PM
CG Oncology Reports Positive First Results from CO...
Source: Na
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-2.69 $-.9 $-.71
Diluted EPS $-2.69 $-.9 $-.71
Revenue $6.23M $1.16M $1.08M
Gross Profit
Net Income / Loss $-224.38M $-79.06M $-60.2M
Operating Income / Loss $-252.62M $-86.4M $-66.39M
Cost of Revenue
Net Cash Flow $5.01M $-14.06M $1.21M
PE Ratio